PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism

Jerome T McKay1, Ryan P Egan1, Rama D Yammani1

  • 1Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC 27157;

Insights

Blocking programmed cell death 1 (PD-1) enhances survival against Streptococcus pneumoniae infections. This occurs by boosting B cell responses, highlighting PD-1 as a target for improving immunity to encapsulated bacteria.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • The programmed cell death 1 (PD-1) and its ligands (PD-L) pathway is a key regulator of immune responses.
  • Its role in bacterial infections, particularly extracellular bacterial infections, remains largely unexplored.

Purpose of the Study:

  • To investigate the role of the PD-1:PD-L pathway in host defense against Streptococcus pneumoniae infection.
  • To determine if targeting PD-1 can enhance protective immunity against pneumococcal infections.

Main Methods:

  • Utilized PD-1 knockout mice and PD-1 blocking antibodies in a mouse model of Streptococcus pneumoniae infection.
  • Assessed B cell proliferation, isotype switching, and IgG production in response to pneumococcal antigens.
  • Investigated the B cell-intrinsic role of PD-1 expression.

Main Results:

  • Disruption of PD-1:PD-L interactions significantly increased survival against lethal S. pneumoniae infection.
  • Enhanced survival was associated with increased proliferation, isotype switching, and IgG production by B cells specific for pneumococcal capsule.
  • PD-1 was found to be induced on B cells and suppressed IgG production and protection in a B cell-intrinsic manner.

Conclusions:

  • B cell-expressed PD-1 plays a critical role in regulating host defense against Streptococcus pneumoniae.
  • The PD-1:PD-L pathway, particularly through B7-H1 and B7-DC, suppresses protective IgG responses to pneumococcal infection.
  • Targeting B cell-intrinsic PD-1 represents a potential strategy for enhancing immunity against encapsulated bacteria.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.6K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
119
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
18.7K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
88.1K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
88.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67